Form 4: Day One Biopharmaceuticals CEO Jeremy Bender Reports Stock Transactions
SEC Form 4 Filing
CEO Jeremy Bender reports acquisition and disposal of Day One Biopharmaceuticals stock, including transactions related to RSU settlements and tax liabilities.
Summary
- Jeremy Bender, CEO of Day One Biopharmaceuticals, filed a Form 4 detailing changes in beneficial ownership of the company's stock.
- On May 15, 2024, Bender acquired shares through the vesting of Restricted Stock Units (RSUs).
- Specifically, 3,562, 4,750, and 11,687 shares were acquired through RSU conversions.
- On May 16, 2024, Bender disposed of 7,873 shares at a price of $16.0787 per share.
- This sale was to cover the reporting person's tax liability with respect to the settlement of RSUs.
- Following these transactions, Bender directly owns 654,728 shares of common stock.
- Bender also indirectly owns shares through several grantor retained annuity trusts.
- These trusts include The Jeremy Bender 2022 Grantor Retained Annuity Trust (221,837 shares), The Jeremy Bender 2023 Grantor Retained Annuity Trust (300,025 shares), The Melissa Bender 2022 Grantor Retained Annuity Trust (251,636 shares), and The Melissa Bender 2023 Grantor Retained Annuity Trust (270,226 shares).
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 2022-03-29 | Date of Irrevocable Trust Agreement for The Jeremy Bender 2022 Grantor Retained Annuity Trust and The Melissa Bender 2022 Grantor Retained Annuity Trust. |
| 2023-06-27 | Date of The Jeremy Bender 2023 Grantor Retained Annuity Trust and The Melissa Bender 2023 Grantor Retained Annuity Trust. |
| 2024-05-15 | Date of RSU conversions to common stock. |
| 2024-05-16 | Date of sale of common stock to cover tax liabilities. |
| 2024-05-17 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.